U.S. IPO Week Ahead: One Biotech Takes On A Turbulent IPO Market
Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate’s orphan drug accelerator Cydan, genetic disorder biotech Imara (IMRA) plans to raise $76 million at a […]
